Clinical trial
Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed…
NCT00250640 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00250640 |
|---|---|
| Title | Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years |
| Official title | Open-label, Uncontrolled, Prospective Long-term Observation of Ventavis Inhalation Therapy in the Treatment of Patients With Primary Pulmonary Hypertension up to 4 Years |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypertension, Pulmonary |
| Intervention type | Drug |
| Interventions | Iloprost (Ventavis, BAYQ6256) |
| Enrollment | 106 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Nov 8, 2005 |
| Last update posted | Feb 2, 2015 |
| Countries | France, Germany, Italy, Portugal, Spain, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: